middle.news
Mesoblast’s Ryoncil Sales Soar 60% as New $125M Facility Boosts Growth
10:12am on Friday 9th of January, 2026 AEDT
•
Healthcare
Read Story
Mesoblast’s Ryoncil Sales Soar 60% as New $125M Facility Boosts Growth
10:12am on Friday 9th of January, 2026 AEDT
Key Points
Ryoncil sales rise 60% to US$35.1 million in Q2 2025
New US$125 million five-year facility lowers cost of capital
Full repayment of prior senior secured loan completed
Adult steroid-refractory acute graft-versus-host disease trial planned
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MSB
OPEN ARTICLE